US Stock MarketDetailed Quotes
VBIV VBI Vaccines
- 0.590
- -0.019-3.04%
Close Apr 24 16:00 ET
- 0.580
- -0.010-1.68%
Post 16:58 ET
16.78MMarket Cap-97P/E (TTM)
0.610High0.580Low130.14KVolume0.594Open0.609Pre Close77.35KTurnover0.49%Turnover RatioLossP/E (Static)28.43MShares3.47052wk High2.23P/B15.67MFloat Cap0.45052wk Low--Dividend TTM26.56MShs Float2360.907Historical High--Div YieldTTM4.90%Amplitude0.095Historical Low0.594Avg Price1Lot Size
VBI Vaccines Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 702.40%8.68M | 191.13%853K | 1,989.59%6.62M | 108.09%720K | 284.92%485K | 71.47%1.08M | 261.73%293K | 196.26%317K | 143.66%346K | -58.14%126K |
| Operating revenue | 702.40%8.68M | 191.13%853K | 1,989.59%6.62M | 108.09%720K | 284.92%485K | 71.47%1.08M | 261.73%293K | 196.26%317K | 143.66%346K | -58.14%126K |
| Cost of revenue | 10.92%12.51M | -11.57%2.94M | -5.50%2.53M | 38.10%3.48M | 29.23%3.56M | 4.70%11.28M | 2.12%3.33M | 8.35%2.67M | -4.25%2.52M | 14.18%2.75M |
| Gross profit | 62.48%-3.83M | 31.14%-2.09M | 274.06%4.1M | -26.98%-2.76M | -16.97%-3.07M | -0.54%-10.19M | 4.50%-3.04M | 0.17%-2.36M | 12.68%-2.18M | -24.49%-2.63M |
| Operating expense | -28.12%51.49M | -44.18%10.27M | -44.97%10.57M | -31.45%14.21M | 23.65%16.44M | 23.72%71.63M | 4.01%18.4M | 51.62%19.2M | 48.59%20.73M | -2.16%13.29M |
| Selling and administrative expenses | -24.91%42.14M | -43.94%8.91M | -36.46%9.04M | -27.63%10.92M | 21.54%13.28M | 46.39%56.12M | 26.80%15.89M | 46.70%14.22M | 61.03%15.08M | 62.00%10.93M |
| -General and administrative expense | -24.91%42.14M | ---- | ---- | -27.63%10.92M | ---- | 46.39%56.12M | ---- | ---- | 61.03%15.08M | ---- |
| Research and development costs | -39.75%9.34M | -45.67%1.37M | -69.26%1.53M | -41.66%3.29M | 33.40%3.15M | -20.72%15.51M | -51.26%2.52M | 67.66%4.98M | 23.16%5.64M | -65.46%2.36M |
| Operating profit | 32.40%-55.31M | 42.33%-12.36M | 69.99%-6.47M | 25.90%-16.97M | -22.54%-19.51M | -20.27%-81.82M | -2.72%-21.44M | -43.49%-21.56M | -39.30%-22.9M | -1.42%-15.92M |
| Net non-operating interest income expense | -66.91%-6.4M | -42.47%-1.72M | -96.31%-1.54M | -89.57%-1.71M | -52.02%-1.43M | 18.96%-3.84M | -15.16%-1.21M | 23.39%-786K | -6.63%-901K | 48.12%-940K |
| Non-operating interest income | 19.90%1.66M | -46.36%346K | 5.97%515K | 67.60%300K | 551.95%502K | 272.85%1.39M | 848.53%645K | 515.19%486K | 383.78%179K | -59.04%77K |
| Non-operating interest expense | 54.42%8.06M | 11.55%2.07M | 61.79%2.06M | 85.93%2.01M | 89.87%1.93M | 2.31%5.22M | 65.89%1.85M | 15.11%1.27M | 22.45%1.08M | -49.15%1.02M |
| Other net income (expense) | -12.57%-31.12M | 834.40%14.07M | -333.93%-12.43M | -18.51%-25.95M | -55.05%-6.81M | -1,018.23%-27.65M | -52.01%1.51M | -1,511.33%-2.87M | -11,423.68%-21.9M | -3,084.06%-4.39M |
| Gain on sale of security | 76.26%-6.52M | 900.80%15.07M | -227.96%-8.83M | 72.83%-5.95M | -55.05%-6.81M | -1,012.52%-27.48M | -52.01%1.51M | -1,426.60%-2.69M | -11,423.68%-21.9M | -3,084.06%-4.39M |
| Special income (charges) | -14,202.33%-24.6M | ---1M | -1,993.02%-3.6M | ---20M | ---- | ---172K | --0 | ---172K | --0 | ---- |
| -Less:Impairment of capital assets | --24.6M | --1M | --3.6M | --20M | ---- | --0 | --0 | --0 | --0 | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | --172K | --0 | --172K | ---- | ---- |
| Income before tax | 18.06%-92.84M | 99.94%-13K | 18.90%-20.44M | 2.34%-44.63M | -30.57%-27.75M | -62.43%-113.3M | -12.55%-21.14M | -59.08%-25.21M | -161.50%-45.7M | -20.44%-21.25M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | 18.06%-92.84M | 99.94%-13K | 18.90%-20.44M | 2.34%-44.63M | -30.57%-27.75M | -62.43%-113.3M | -12.55%-21.14M | -59.08%-25.21M | -161.50%-45.7M | -20.44%-21.25M |
| Net income continuous Operations | 18.06%-92.84M | 99.94%-13K | 18.90%-20.44M | 2.34%-44.63M | -30.57%-27.75M | -62.43%-113.3M | -12.55%-21.14M | -59.08%-25.21M | -161.50%-45.7M | -20.44%-21.25M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 18.06%-92.84M | 99.94%-13K | 18.90%-20.44M | 2.34%-44.63M | -30.57%-27.75M | -62.43%-113.3M | -12.55%-21.14M | -59.08%-25.21M | -161.50%-45.7M | -20.44%-21.25M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 1.01M | 143K | 862K | 0 | 0 | 0 | ||||
| Net income attributable to common stockholders | 17.18%-93.84M | 99.26%-156K | 15.48%-21.31M | 2.34%-44.63M | -30.57%-27.75M | -62.43%-113.3M | -12.55%-21.14M | -59.08%-25.21M | -161.50%-45.7M | -20.44%-21.25M |
| Basic earnings per share | 54.18%-6.03 | 99.73%-0.0065 | 65.53%-1.01 | 2.45%-5.18 | -30.36%-3.2168 | -62.47%-13.16 | -16.67%-2.45 | -62.78%-2.93 | -152.86%-5.31 | -17.50%-2.4675 |
| Diluted earnings per share | 54.18%-6.03 | 99.73%-0.0065 | 65.53%-1.01 | 2.45%-5.18 | -30.36%-3.2168 | -62.47%-13.16 | -16.67%-2.45 | -62.78%-2.93 | -152.86%-5.31 | -17.50%-2.4675 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg